FXH First Trust Health Care AlphaDEX® ETF
StrataQuant Health Care TR USD

NAV as of 20-May-2022

106.4200

4 Week: 101.87 - 111.22

52 Week: 101.87 - 128.11

Latest Closing Price

107.38

Premium / Discount

-0.07

Expense Ratio

0.61%

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.

Main Fund Characteristics

Fund Manager:
First Trust
Asset Under Management:
1,418,099,775
Launch Date:
07/05/2007
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
86
Trading Currency:
USD
Style:
Mid Blend
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-13.511.43-9.46
1 Day0.980.000.00
1 Week1.694.150.41
1 Month-2.997.76-0.39
3 Months-0.3512.18-0.03
6 Months-10.1215.17-0.67
1 Year-5.6217.19-0.33
2 Years20.2225.660.79
3 Years48.3639.921.21
5 Years68.0446.701.46
10 Years264.7458.304.54

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 20.807347.460125.39520.2322-5.196121.7839-1.261322.310927.854315.1768
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 36.000050.000067.0000100.000023.000057.000065.000065.000036.000030.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
20/06/201327/06/20130.0055
20/12/201230/12/20120.1235
20/06/201228/06/20120.0170
20/06/201129/06/20110.0316
20/12/201030/12/20100.0292

Portfolio Data

Total Number of Holdings: 86

Number of Bond Holdings: 0

Number of Equity Holdings: 85

Total Market Value: 1,418,099,775

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1United Therapeutics Corp2.1794165,584030,962,552

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant14.53
Large24.41
Medium48.67
Small12.19
Micro0.00

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

14.0112

Price/Book*

2.5743

Price/Sales*

1.3536

Price/Cash Flow*

9.7280

Dividend Yield*

1.9246

Growth Measures

Long-Term Earnings

12.0535

Historical Earnings

23.8717

Sales Growth

9.5679

Cash-Flow Growth

12.7109

Book-Value Growth

13.5373

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.